Cost-effectiveness analysis: what is it and how will it influence neurology.
Cost-effectiveness analysis (CEA) refers to a set of research methods that consider the resources consumed by a medical technology in decisions about how best to use the technology. This analytic method is an evolving, controversial, and often misunderstood field in health services research. The basic set of principles underlying CEA is deceptively simple, but sufficient methodological challenges and controversies exist that have, thus far, limited its use in the development of health policy and in bedside decision making. Nonetheless, neurologists like other specialty groups may feel concerned that the results from such analyses may prove unfavorable to their specialty and the patients they serve. This article reviews the fundamental notions surrounding CEA, provides examples from the literature with particular relevance to the neurological community, and highlights critical issues for neurologists regarding the future of CEA.
Holloway
R G
RG
Department of Neurology, University of Rochester School of Medicine and Dentistry, NY 14642, USA.
D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D017048:Health Care Costs; D006801:Humans; D013677:Medical Laboratory Science / Q000191:economics; D009462:Neurology / Q000191:economics*